RxDoctor Payments Data

Sara Enrico

Family · Phoenix, AZNPI 1033884762

Payments from drug & device makers

$2,041in general payments, 2019–2025

Across 128 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$698
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$468
  • Pfizer$151
  • Boston Scientific$150
  • Biohaven Pharmaceutical Holding Company Ltd.$101
  • Curonix LLC$80
  • plus $392 from 13 others

What the payments were for

  • Food & beverage$2,041100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,041 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$77,662
Medicare patients
182
Services billed
887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen663$25,196
MovantikNaloxegol Oxalate34$15,570
Nucynta ErTapentadol Hcl11$13,140
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen404$12,391
Emgality PenGalcanezumab-Gnlm16$11,331
Xtampza ErOxycodone Myristate34$10,632
Oxycodone Hcl428$6,369
Gabapentin362$5,614
Lidocaine-PrilocaineLidocaine/Prilocaine11$4,339
Lidocaine37$3,638
Morphine Sulfate ErMorphine Sulfate234$3,624
Fentanyl30$3,386
Pregabalin124$3,350
OxycontinOxycodone Hcl11$2,750
Tizanidine Hcl198$2,593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er$76$23,77345 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,119 family providers in Arizona.

Other family in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →